核心专利
研究团队持有及申请的主要专利如下。
- US 7,381,819 B2 — Composition and method for treating/preventing endometritis
- KOREA 10-2015-0009682 — Stem-cell induction medium containing RGMc, and induction method
- KOREA 10-2006-0119155 — Composition containing RNA molecules for treating/preventing endometrial cancer
- KOREA 10-2008-0011933 — PNA-variant compound with antibacterial activity
- KOREA 10-0895324 — Inducing differentiation of insulin-secreting cells from adult stem cells
- KOREA 10-0683198 — Method and medium for differentiating neural progenitors into dopaminergic neurons
- KOREA 10-0683199 — Method and medium for differentiating neural progenitors into cholinergic neurons
- KOREA 10-2008-0095467 — Hepatocyte differentiation from adipose/placental-derived adult stem cells
- KOREA 10-2010-0045281 — Method for inducing insulin-secreting-cell differentiation from adult stem cells
循证研究成果
该专利组合是长期学术研究的成果，支撑着世宗ABin独有的差异化技术资产——独家诱导培养基（RGMc）、神经与代谢疾病分化技术，以及RNA/PNA核酸平台。
本内容旨在提供一般性信息，个人的治疗效果可能因人而异。